
Daxxify (daxibotulinumtoxinA-lanm) is the newest FDA-approved neuromodulator in the U.S. It works similarly to Botox, Dysport, and Xeomin by relaxing muscles that cause dynamic wrinkles.
What makes Daxxify unique is that it uses a peptide-based stabilizing technology instead of human serum albumin and is known for its longer-lasting results.
It is FDA-approved for:
Like other botulinum toxin type A products, Daxxify:
The difference isn't how it works—it's how long the effects may last.
Most providers recommend:
This is generally comparable to Dysport and Botox.
This is where Daxxify stands out.
Compare that to:
As a result, some Daxxify patients only need 2 treatments per year instead of 3–4.
Usually mild:
Less common:
Rare but serious:
Seek immediate medical attention if severe symptoms occur.
What is Daxxify®?
Daxxify® is an FDA-approved injectable treatment that uses botulinum toxin type A to temporarily relax facial muscles and reduce the appearance of forehead lines, frown lines, and crow’s feet. It is designed to deliver smooth, natural-looking results and is known for its longer-lasting effects compared to some other wrinkle relaxers.
Why choose Daxxify®?
Daxxify® is often chosen for its long-lasting wrinkle-smoothing results, with many patients enjoying visible improvement for up to six months or longer. It helps soften forehead lines, frown lines, and crow’s feet while maintaining natural facial movement and reducing the need for frequent treatments.